BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Cambridge AI Club for Biomedicine - October 2024 - Andrew McDonald
  (Biophonics and University of Cambridge) and Philip Martin (Marks &amp\; 
 Clerk LLP)
DTSTART:20241003T163000Z
DTEND:20241003T180000Z
UID:TALK220786@talks.cam.ac.uk
CONTACT:Mary-Jane Roebuck
DESCRIPTION:Join us for the October meeting of the Cambridge AI Club for B
 iomedicine. No registration necessary - just show up. The October meeting 
 is held in collaboration with Cambridge Enterprise. \n\n\n5.15pm – Doors
  (and bar)\n5:30-6:30pm  – Talks and panel discussion\n6:30pm  –  Pizz
 a\n\nOctober theme: Commercialisation of AI\n\nSpeaker 1: Andrew McDonald 
 (Biophonics and Department of Engineering\, University of Cambridge)\n\nTi
 tle: "Biophonics: commercialising an AI-enabled medical device to screen f
 or valvular heart disease"\n\nBio: Andrew is the co-founder of Biophonics\
 , a new spin-out from the Engineering Department at the University of Camb
 ridge. He was awarded a PhD by the University of Cambridge in 2021 for the
  development of machine learning algorithms to detect valvular heart disea
 se in heart sound recordings. Over the past seven years\, he has collabora
 ted with NHS cardiologists to develop and validate novel screening algorit
 hms\, with a US patent granted. The technology won the international 2022 
 George B. Moody PhysioNet Challenge and has been featured at the UK parlia
 ment and on BBC and ITV News.\n\nSpeaker 2: Philip Martin (Marks & Clerk L
 LP)\n\nTitle:"Biomedical AI and patents"\n\nBio: Philip has a physics degr
 ee and started his career with teaching and a PhD\, then worked as an elec
 tronics engineer for a period\, before moving into patents\, sitting exams
 \, and qualifying as a patent attorney – all rather a long time ago now.
  His career as a patent attorney has involved working with many Cambridge 
 start-ups\, and some high value and contentious matters\, including a stri
 ng of oppositions in the EPO that is\, perhaps\, unparalleled. For the pas
 t few years he has been fortunate enough to work on European patents with 
 the world’s leading AI research company.\n\n\nFor more information\, vis
 it: https://www.milner.cam.ac.uk/ai-club/
LOCATION: Jeffrey Cheah Biomedical Centre Lecture Theatre
END:VEVENT
END:VCALENDAR